Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept
| Image |  |
|---|---|
| Description | scientific article published on 10 January 2017 |
| Author/s |
author: Mark G. Lebwohl |
| Publication date | January 10, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |